Form 483

Ex-Lax, Inc. Form 483, 2017-03-31

FDA issued a Form 483 to Ex-Lax, Inc. on 2017-03-31 with 14 public-safe observations.

483· Form 483 issuedHuman Drugs14 observations

Ex-Lax, Inc. · Humacao, United States · Issued March 31, 2017

Overview

  • 14 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 Mar 2017
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Noreen Muniz, Edwin Martinez

31 Mar 2017
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Noreen Muniz, Edwin Martinez

31 Mar 2017
21 CFR 211.160(a)

Deviations from laboratory control requirements

Cited by Noreen Muniz, Edwin Martinez

31 Mar 2017
21 CFR 211.160(a)

Deviations from laboratory control requirements

Cited by Noreen Muniz, Edwin Martinez

31 Mar 2017
21 CFR 211.160(b)(4)

Calibration - at intervals, written program, remedial action

Cited by Noreen Muniz, Edwin Martinez

Inspected site

EIEx-Lax, Inc.Humacao, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations4x
21 CFR 211.110(a)Cited across public-safe Form 483 observations2x
21 CFR 211.160(a)Cited across public-safe Form 483 observations2x
21 CFR 211.188Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 14 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere